Rhoen Klinikum Valuation Multiples

Discover revenue and EBITDA valuation multiples for Rhoen Klinikum and similar public comparables like HCG Hospitals, Terveystalo, Clinica Baviera, Life Healthcare Group and more.

Rhoen Klinikum Overview

About Rhoen Klinikum

Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.


Founded

1973

HQ

Germany

Employees

18.7K

Financials (LTM)

Revenue: $2B
EBITDA: $132M

EV

$761M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Rhoen Klinikum Financials

Rhoen Klinikum reported last 12-month revenue of $2B and EBITDA of $132M.

In the same LTM period, Rhoen Klinikum generated $132M in EBITDA and $45M in net income.

Revenue (LTM)


Rhoen Klinikum P&L

In the most recent fiscal year, Rhoen Klinikum reported revenue of $2B and EBITDA of $130M.

Rhoen Klinikum is profitable as of last fiscal year, with gross margin of 11%, EBITDA margin of 7%, and net margin of 2%.

See analyst estimates for Rhoen Klinikum
LTMLast FY202320242025202620272028
Revenue$2B$2B$1.7B$1.8B$2B
Gross Profit-$221M$171M$197M$221M
Gross Margin-11%10%11%11%
EBITDA$132M$130M$134M$140M$130M
EBITDA Margin7%7%8%8%7%
EBIT Margin3%2%3%2%2%
Net Profit$45M$40M$44M$50M$40M
Net Margin2%2%3%3%2%

Financial data powered by Morningstar, Inc.

Rhoen Klinikum Stock Performance

Rhoen Klinikum has current market cap of $1B, and enterprise value of $761M.

Market Cap Evolution


Rhoen Klinikum's stock price is $15.14.

Rhoen Klinikum share price increased by 2.0% in the last 30 days, and by 10.3% in the last year.

Rhoen Klinikum has an EPS (earnings per share) of $0.59.

See more trading valuation data for Rhoen Klinikum
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$761M$1B-0.4%2.0%4.5%10.3%$0.59

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Rhoen Klinikum Valuation Multiples

Rhoen Klinikum trades at 0.4x EV/Revenue multiple, and 5.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Rhoen Klinikum

EV / Revenue (LTM)


Rhoen Klinikum Financial Valuation Multiples

As of July 17, 2026, Rhoen Klinikum has market cap of $1B and EV of $761M.

Rhoen Klinikum has a P/E ratio of 22.7x.

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.4x0.5x0.4x0.4x
EV/EBITDA5.8x5.9x5.7x5.4x5.9x
EV/EBIT14.3x16.1x16.9x17.7x22.9x
EV/Gross Profit-3.4x4.5x3.9x3.4x
P/E22.7x25.6x22.8x20.4x25.6x
EV/FCF43.7x31.5x14.4x11.6x(15.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Rhoen Klinikum Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Rhoen Klinikum Margins & Growth Rates

Rhoen Klinikum grew revenue by 4% and EBITDA by 8% in the last fiscal year.

In the most recent fiscal year, Rhoen Klinikum reported gross margin of 11%, EBITDA margin of 7%, and net margin of 2%.

See estimated margins and future growth rates for Rhoen Klinikum

Rhoen Klinikum Margins

Last FY202420252026202720282029
Gross Margin11%11%11%-
EBITDA Margin7%8%7%7%
EBIT Margin2%2%2%3%
Net Margin2%3%2%2%
FCF Margin1%4%(2%)1%

Rhoen Klinikum Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%9%7%5%
Gross Profit Growth-15%12%-
EBITDA Growth8%4%(7%)8%
EBIT Growth23%(5%)(23%)76%
Net Profit Growth23%12%(20%)24%
FCF Growth(51%)24%(173%)(125%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Rhoen Klinikum Operational KPIs

Rhoen Klinikum's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Rhoen Klinikum's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Rhoen Klinikum's Rule of X is 19% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Rhoen Klinikum
LTMLast FY202320242025202620272028
Rule of 4011%12%---
Bessemer Rule of X18%19%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue-4%5%4%4%
Opex to Revenue-10%7%8%10%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Rhoen Klinikum Competitors

Rhoen Klinikum competitors include HCG Hospitals, Terveystalo, Clinica Baviera, Life Healthcare Group, Thomson Medical, Dr. Sulaiman Al Habib Medical Services, Nutex Health, U.S. Physical Therapy, Spire Healthcare Group and Saudi German Health.

Most Rhoen Klinikum public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
HCG Hospitals4.3x4.2x23.8x22.2x
Terveystalo1.1x1.2x5.7x6.2x
Clinica Baviera3.1x2.9x10.9x10.3x
Life Healthcare Group0.8x0.8x5.2x4.8x
Thomson Medical6.1x-41.6x-
Dr. Sulaiman Al Habib Medical Services3.1x-11.3x-
Nutex Health1.5x1.4x4.4x5.3x
U.S. Physical Therapy1.9x1.8x13.3x14.7x

This data is available for Pro users. Sign up to see all Rhoen Klinikum competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Rhoen Klinikum

When was Rhoen Klinikum founded?Rhoen Klinikum was founded in 1973.
Where is Rhoen Klinikum headquartered?Rhoen Klinikum is headquartered in Germany.
How many employees does Rhoen Klinikum have?As of today, Rhoen Klinikum has over 18K employees.
Is Rhoen Klinikum publicly listed?Yes, Rhoen Klinikum is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Rhoen Klinikum?Rhoen Klinikum trades under RHK ticker.
When did Rhoen Klinikum go public?Rhoen Klinikum went public in 1989.
Who are competitors of Rhoen Klinikum?Rhoen Klinikum main competitors include HCG Hospitals, Terveystalo, Clinica Baviera, Life Healthcare Group, Thomson Medical, Dr. Sulaiman Al Habib Medical Services, Nutex Health, U.S. Physical Therapy, Spire Healthcare Group, Saudi German Health.
What is the current market cap of Rhoen Klinikum?Rhoen Klinikum's current market cap is $1B.
What is the current revenue of Rhoen Klinikum?Rhoen Klinikum's last 12 months revenue is $2B.
What is the current revenue growth of Rhoen Klinikum?Rhoen Klinikum revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Rhoen Klinikum?Current revenue multiple of Rhoen Klinikum is 0.4x.
What is the current EBITDA of Rhoen Klinikum?Rhoen Klinikum's last 12 months EBITDA is $132M.
What is Rhoen Klinikum's EBITDA margin?Rhoen Klinikum's last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of Rhoen Klinikum?Current EBITDA multiple of Rhoen Klinikum is 5.8x.
What is the current FCF of Rhoen Klinikum?Rhoen Klinikum's last 12 months FCF is $17M.
What is Rhoen Klinikum's FCF margin?Rhoen Klinikum's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Rhoen Klinikum?Current FCF multiple of Rhoen Klinikum is 43.7x.
How many companies Rhoen Klinikum has acquired to date?Rhoen Klinikum hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Rhoen Klinikum has invested to date?Rhoen Klinikum hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Rhoen Klinikum

Lists including Rhoen Klinikum

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial